BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3851
VanEck Morningstar Wide Moat ETF
MOAT
$12.8B
| $8.53K | ﹤0.01% |
92
-318
| -78% | -$29.5K |
|
3852
iShares Core S&P US Growth ETF
IUSG
$25.2B
| $8.5K | ﹤0.01% |
61
+17
| +39% | +$2.37K |
|
3853
Roadzen
RDZN
$74.5M
| $8.36K | ﹤0.01% |
+3,835
| New | +$8.36K |
|
3854
ICL Group
ICL
$7.99B
| $8.16K | ﹤0.01% |
+1,652
| New | +$8.16K |
|
|
FORTY
3855
Formula Systems
FORTY
$2.22B
| $8.11K | ﹤0.01% |
100
| – | – |
|
3856
iShares MSCI Thailand ETF
THD
$236M
| $7.92K | ﹤0.01% |
131
-85
| -39% | -$5.14K |
|
3857
Golden Matrix Group
GMGI
$144M
| $7.9K | ﹤0.01% |
+3,991
| New | +$7.9K |
|
3858
Mural Oncology
MURA
$35.9M
| $7.82K | ﹤0.01% |
2,427
-25,621
| -91% | -$82.5K |
|
|
TECX
3859
Tectonic Therapeutic, Inc. Common Stock
TECX
$337M
| $7.8K | ﹤0.01% |
+169
| New | +$7.8K |
|
3860
Tower Semiconductor
TSEM
$7.38B
| $7.78K | ﹤0.01% |
151
-303
| -67% | -$15.6K |
|
3861
First Community Corp
FCCO
$216M
| $7.63K | ﹤0.01% |
318
+221
| +228% | +$5.3K |
|
3862
VirTra
VTSI
$63.4M
| $7.61K | ﹤0.01% |
1,127
-3,908
| -78% | -$26.4K |
|
|
TSBX
3863
DELISTED
Turnstone Biologics
TSBX
| $7.57K | ﹤0.01% |
+15,238
| New | +$7.57K |
|
3864
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $7.49K | ﹤0.01% |
96
-606,335
| -100% | -$47.3M |
|
3865
WhiteHorse Finance
WHF
$204M
| $7.47K | ﹤0.01% |
+772
| New | +$7.47K |
|
|
PT
3866
Pintec Technology Holdings
PT
$16.3M
| $7.47K | ﹤0.01% |
+8,300
| New | +$7.47K |
|
3867
Invesco FTSE RAFI US 1000 ETF
PRF
$8.21B
| $7.46K | ﹤0.01% |
185
-472
| -72% | -$19K |
|
3868
FibroBiologics
FBLG
$23.7M
| $7.39K | ﹤0.01% |
3,697
-1,724
| -32% | -$3.45K |
|
3869
Senseonics Holdings
SENS
$371M
| $7.37K | ﹤0.01% |
14,074
| – | – |
|
3870
Purple Innovation
PRPL
$116M
| $7.34K | ﹤0.01% |
9,412
-3,383
| -26% | -$2.64K |
|
3871
Actinium Pharmaceuticals
ATNM
$52.4M
| $7.24K | ﹤0.01% |
+5,744
| New | +$7.24K |
|
3872
Galectin Therapeutics
GALT
$381M
| $7.22K | ﹤0.01% |
5,600
+145
| +3% | +$187 |
|
|
ONCY
3873
Oncolytics Biotech
ONCY
$133M
| $7.13K | ﹤0.01% |
7,800
-5,911
| -43% | -$5.4K |
|
|
ZEPP
3874
Zepp Health
ZEPP
$719M
| $7.09K | ﹤0.01% |
2,725
+200
| +8% | +$520 |
|
3875
Critical Metals Corp
CRML
$614M
| $6.79K | ﹤0.01% |
1,000
-2,674
| -73% | -$18.2K |
|